Antidepressants Aren't One-Size-Fits-All—Here's Why

Learn about: - The limitations of one-size-fits-all antidepressants. - The role of genetics, environment, and personal history in depression. - Adjunct therapy as a new horizon in mental healthcare. - CAPLYTA® (lumateperone), an FDA-approved add-on treatment for adults with MDD. - Important coping strategies and the power of holistic health. This discussion, made in collaboration with Johnson & Johnson, aims to foster mental health awareness and education. **RESOURCES MENTIONED:** Learn more about the add-on treatment discussed: ► CAPLYTA® (lumateperone): https://www.caplyta.com If you or someone you know needs support, please reach out: ► Suicide & Crisis Lifeline: Call or text 988 (Available 24/7) Learn more about Depression, Adjunct Medications, and Caplyta here:► https://gotohealthmedia.com/antidepressants-arent-one-size-fits-all-heres-why/ **DISCLAIMER:** This Interview is for informational and educational purposes only and does not constitute medical advice. The information provided is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have seen in this video. Reliance on any information provided in this video is solely at your own risk.   If you're enjoying the Show, it would mean the world to us if you took a second to leave a five star review on YouTube, Apple Podcasts, or Spotify, or wherever you're listening to us. It helps more people find the show and lets us know we're on the right track. We thank you in advance Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising. Learn more about your ad choices. Visit megaphone.fm/adchoices